pharmaceutical investing Ironwood and Alnylam Enter US GI Disease Education and Promotional Agreement
pharmaceutical investing Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
pharmaceutical investing Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C
Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease
Surface Metals to Present at Fastmarkets Global Lithium, Battery & Critical Materials Conference in Las Vegas, Nevada
Nine Mile Metals Announces Completion of DDH WD-26-02,Intersecting 234.15 Meters of Visual Mineralization and Discovers a New Copper Rich VMS Horizon at the Wedge Mine
Freegold intersects 336.8 m grading 1.32 g/t Au starting from 26.5 m in Infill Drilling at Golden Summit
